Yan-Ming Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan-Ming Chen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Chang Ye
Department of Chemistry, The University of Chicago, Chicago, USA
2 shared publications - Chuan He
Department of Chemistry, University of Chicago, Chicago, USA
2 shared publications - Yu Xiao
Department of Chemistry, The University of Chicago, Chicago, USA
2 shared publications - Zhongyu Zou
Department of Chemistry, The University of Chicago, Chicago, USA
2 shared publications - Bo Tao
Department of Biomedical Engineering, Yale University, New Haven, USA
1 shared publication - Chang Liu
Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication
Latest Publications
- 9 June 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (7) , 1318-1326
Spatially resolved m6A profiling using m6A-ARTR-DBiT
N6-methyladenosine (m6A) on RNA plays diverse regulatory roles, yet its spatial distribution within tissues remains largely unexplored. Here we introduce m6A-ARTR-DBiT, a spatial m6A profiling assay that leverages reverse-transcription-based detection and deterministic barcoding in tissue to map transcriptome-wide m6A distribution while preserving native tissue context. Applying m6A-ARTR-DBiT to mouse embryonic tissues and adult brains generates spatially resolved m6A landscapes and reveals region-associated m6A features across different functional domains. Pairwise comparison of spatial m6A profiles with spatial transcriptomes uncovers positive correlations between m6A levels and the expression of its methyltransferases and binding proteins, which also enables systematic identification of tissue-region-specific epitranscriptomic regulation. In the mouse hippocampus, m6A-ARTR-DBiT allows for high-resolution mapping of m6A organization within fine-scale tissue structures. Together, m6A-ARTR-DBiT provides a platform for interrogating RNA modification distribution within intact tissue sections, offering insights into the link between spatially patterned m6A deposition and gene regulation.
- 9 June 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (7) , 1318-1326
Spatially resolved m6A profiling using m6A-ARTR-DBiT
N6-methyladenosine (m6A) on RNA plays diverse regulatory roles, yet its spatial distribution within tissues remains largely unexplored. Here we introduce m6A-ARTR-DBiT, a spatial m6A profiling assay that leverages reverse-transcription-based detection and deterministic barcoding in tissue to map transcriptome-wide m6A distribution while preserving native tissue context. Applying m6A-ARTR-DBiT to mouse embryonic tissues and adult brains generates spatially resolved m6A landscapes and reveals region-associated m6A features across different functional domains. Pairwise comparison of spatial m6A profiles with spatial transcriptomes uncovers positive correlations between m6A levels and the expression of its methyltransferases and binding proteins, which also enables systematic identification of tissue-region-specific epitranscriptomic regulation. In the mouse hippocampus, m6A-ARTR-DBiT allows for high-resolution mapping of m6A organization within fine-scale tissue structures. Together, m6A-ARTR-DBiT provides a platform for interrogating RNA modification distribution within intact tissue sections, offering insights into the link between spatially patterned m6A deposition and gene regulation.
- Open Access
- 10 January 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (2) , 247-258
Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
RNA-binding proteins (RBPs) regulate diverse cellular processes by dynamically interacting with RNA targets. However, effective methods to capture both stable and transient interactions between RBPs and their RNA targets are still lacking, especially when the interaction is dynamic or samples are limited. Here we present an assay of reverse transcription-based RBP binding site sequencing (ARTR-seq), which relies on in situ reverse transcription of RBP-bound RNAs guided by antibodies to identify RBP binding sites. ARTR-seq avoids ultraviolet crosslinking and immunoprecipitation, allowing for efficient and specific identification of RBP binding sites from as few as 20 cells or a tissue section. Taking advantage of rapid formaldehyde fixation, ARTR-seq enables capturing the dynamic RNA binding by RBPs over a short period of time, as demonstrated by the profiling of dynamic RNA binding of G3BP1 during stress granule assembly on a timescale as short as 10 minutes.
- 10 January 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (2) , 247-258
Open AccessProfiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
RNA-binding proteins (RBPs) regulate diverse cellular processes by dynamically interacting with RNA targets. However, effective methods to capture both stable and transient interactions between RBPs and their RNA targets are still lacking, especially when the interaction is dynamic or samples are limited. Here we present an assay of reverse transcription-based RBP binding site sequencing (ARTR-seq), which relies on in situ reverse transcription of RBP-bound RNAs guided by antibodies to identify RBP binding sites. ARTR-seq avoids ultraviolet crosslinking and immunoprecipitation, allowing for efficient and specific identification of RBP binding sites from as few as 20 cells or a tissue section. Taking advantage of rapid formaldehyde fixation, ARTR-seq enables capturing the dynamic RNA binding by RBPs over a short period of time, as demonstrated by the profiling of dynamic RNA binding of G3BP1 during stress granule assembly on a timescale as short as 10 minutes.